ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation

A. Meesing,1 R. Abraham,2 R. Razonable.1

1Division of Infectious Diseases, Mayo Clinic, Rochester, MN
2Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Meeting: 2018 American Transplant Congress

Abstract number: C315

Keywords: Cytomeglovirus, Infection

Session Information

Session Name: Poster Session C: Transplant Infectious Diseases

Session Type: Poster Session

Date: Monday, June 4, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Introduction: Control of cytomegalovirus (CMV) infection after solid organ transplantation (SOT) requires a functional immune system. We assessed the utility of a flow cytometric assay quantifying CMV-specific CD8+ T cells in predicting the outcome of CMV infection and disease after SOT.

Methods: During 2007-2017, selected kidney, heart, lung, pancreas, liver and composite tissue transplant patients with CMV infection and disease were tested for CMV-specific CD8+ T cell immune competence, as measured by quantitating the number of CMV-CD8+ T cells using MHC class I tetramers with CMV-specific peptides, and assessing their function by antigen-specific interferon-gamma (IFNg) production and CD107a/b degranulation. As a positive control for global CD8+ T cell immune function, IFNg production and CD107 degranulation in response to mitogenic stimulus (PMA and ionomycin) was measured. The quantitative and functional data was used to assemble a T cell immune competence score (TIC). CMV infection was diagnosed by quantitative PCR in blood and other samples, or histopathology. The TIC score and measures of global immune function were correlated with CMV outcomes.

Results: Of the 130 SOT patients tested, 72 had active CMV infection or disease. Gender distribution was equal. The median age was 57.5 years (IQR: 47.8-64). The median onset to CMV infection and disease was 11.9 months (IQR 7.32-21.63). CMV syndrome (45%), gastrointestinal disease (24%) and pneumonia (17%) were most common clinical presentation. Impaired TIC score or global CD8+ T cell function was associated with invasive CMV disease (OR 5.2, p=0.03). Patients with normal TIC score had shorter duration of CMV viremia (20.7 vs. 33.5 days, p=0.003) (Figure 1). Patients with normal global CD8+ T cell immune function had lower risk of CMV relapse (22.6 vs. 52.9%, p=0.02).

Conclusion: CMV-specific and global CD8+ T cell immune function is associated with clinical course of CMV infection and disease after solid organ transplantation, and has the potential to assist in its clinical management.

CITATION INFORMATION: Meesing A., Abraham R., Razonable R. CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Meesing A, Abraham R, Razonable R. CMV-Specific CD8+ T-Cell Immune Competence Score as Predictor of Outcome for CMV Infection after Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/cmv-specific-cd8-t-cell-immune-competence-score-as-predictor-of-outcome-for-cmv-infection-after-transplantation/. Accessed June 2, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences